Patients’ Preference Regarding Patient-Reported Outcome Measures for Hidradenitis Suppurativa: A Cross-Sectional Multicenter Study Authors: Johanna C. van Huijstee, Nicole D.K. Koerts, Colin C. Spence, Renske Schappin, Barbara Horvath, Hessel H. van der Zee Published: 2026 ABSTRACT AbstractIntroductionOver the last decade, research interest in hidradenitis suppurativa (HS) has grown exponentially, resulting in a need for accurate outcome measures. However, subjective outcome measures included in research have not always been those that patients regard as most important or relevant. Therefore, this manuscript evaluates the preference of patients concerning three different patient-reported outcome measures (PROMs), the DLQI, HiSQOL, and Skindex-17.MethodsThis cross-sectional, multicenter study in the Netherlands included HS patients who completed the PROMs, each followed by the QQ-10 questionnaire. Their preference regarding these PROMs was evaluated using value and burden scores of the QQ-10 questionnaire, a ranking system, and open-end responses.ResultsA total of 200 patients were included in the study. The QQ-10 value scores for the DLQI, HiSQOL, and Skindex-17 were 66.3%, 67.1%, and 69.2%, respectively. The HiSQOL and Skindex-17 had a similar mean burden score of 23.8%, while the DLQI had a burden score of 24.4%. The Skindex-17 was ranked first by 41.5% of patients, followed by the HiSQOL (31.5%) and DLQI (27%). The Skindex-17 received the most negative feedback (85 comments), followed by the DLQI (84 comments), with both questionnaires receiving criticism primarily focused on their content. The HiSQOL received 57 comments, mainly concerning its design.ConclusionPatients did not demonstrate a clear preference among the three PROMs based on value and burden scores. However, qualitative feedback from open-ended responses suggests that the HiSQOL may be preferable, given its inclusion of HS-specific symptoms. Introduction Over the last decade, research interest in hidradenitis suppurativa (HS), a chronic, inflammatory, and debilitating skin disease, has grown exponentially. The disease is characterized by recurrent and painful abscesses, nodules, sinus tracts, and scarring [1]. HS profoundly affects patients’ quality of life, mostly driven by symptoms such as pain, malodor and, embarrassment [2]. The symptom burden of HS can result in greater impairment of patients’ quality of life compared to other dermatological conditions, such as atopic dermatitis, psoriasis, or non-melanoma skin cancer [3, 4]. With the rise in research interest and clinical trials, there is an increasing need for reliable outcome measures [5]. Patient-reported outcome measures (PROMs) are essential tools for evaluating patients’ experiences, symptoms, disease severity, and quality of life. Commonly used PROMs in HS research and clinical practice include the Dermatology Life Quality Index (DLQI), the Hidradenitis Suppurativa Quality of Life (HiSQOL), and the Skindex-17, all of which are validated questionnaires evaluating the quality of life [5–8]. However, to our knowledge, no data exist on patients’ perspectives of these questionnaires, nor has there been a direct comparison of them based on patient preferences. Since outcome measures used in studies may not always align with what patients consider most important or relevant, this represents a scientific gap [9]. To address this, we conducted a prospective observational study using the validated QQ-10 questionnaire to evaluate patients’ perceptions of the different PROMs. Methods Study Participants This cross-sectional, multicenter study was carried out between September 2023 and March 2024, in the dermatology departments of two tertiary hospitals in the Netherlands. Adult patients with HS were recruited from the outpatient clinics of the Erasmus Medical Center Rotterdam (EMC) and the University Medical Center Groningen (UMCG) after their clinical visits. Patients aged 16 and above were eligible for inclusion if they had been diagnosed with HS and were capable of reading Dutch. Written informed consent was obtained from all patients. Questionnaires Three validated dermatological quality of life questionnaires were administered: the DLQI, HiSQOL, and Skindex-17. The DLQI is a widely used dermatology-specific health-related quality of life questionnaire consisting of ten questions [6]. Similarly, the Skindex-17 is a 17-item quality of life questionnaire designed for dermatological patients [7]. The HiSQOL is an HS-specific questionnaire comprising 17 questions [8]. Developed by Moores et al. [10], the QQ-10 questionnaire is a ten-item instrument assessing positive value and negative burden of a PROM. Preferably, you would want a PROM to have a high value score and a low burden score. The value of the different questionnaires was evaluated through the following questions: whether it facilitated communication about the condition, its relevance to the condition, ease of completion, comprehensiveness in covering all aspects of the condition, enjoyment, and willingness to include it as part of routine care. The burden score was assessed based on four potential negative aspects of the questionnaire: being overly long, embarrassing, complicated, or upsetting. This questionnaire was developed using standard psychometric methods and has been shown to have high interval consistency and item correction, as well as being acceptable and understandable to patients. Responses are rated on a five-point Likert scale, ranging from 4 points (strongly agree) to 0 points (strongly disagree), yielding a maximum of 24 value points (equals 100%) and 16 burden points (equals 100%). The DLQI, HiSQOL, and Skindex-17 questionnaires were already available in Dutch. The QQ-10 questionnaire was subsequently translated into Dutch in accordance with the POEM checklist of the University of Nottingham [11]. Demographics Patient characteristics, such as sex, age, and BMI, as well as disease characteristics, including the IHS4 (International Hidradenitis Suppurativa Severity Score) and refined Hurley classification, were collected from the electronic patient files. Study Procedures As part of routine care, all patients completed the DLQI, HiSQOL, and Skindex-17. Hereafter, the patients were asked to complete the QQ-10 questionnaire to provide their perspectives on the various PROMs. To reduce sequence bias, the order in which the PROMs were administered was at random. The time to complete each questionnaire was recorded. Upon completion, patients were asked to rank the questionnaires based on the following criteria:The importance of the questions for their condition;the adequacy of the questionnaire in reflecting the impact of the disease on their daily life;the effort required to complete the questionnaires. The importance of the questions for their condition; The importance of the questions for their condition; the adequacy of the questionnaire in reflecting the impact of the disease on their daily life; the adequacy of the questionnaire in reflecting the impact of the disease on their daily life; the effort required to complete the questionnaires. the effort required to complete the questionnaires. Data Analysis Primary outcomes of this study were the value and burden scores for the three different PROMs. Secondary outcomes included value and burden scores categorized by sex, age, and disease severity. Furthermore, the time taken to complete each questionnaire, the ranking of the PROMs, and the open end responses were assessed. Results are presented as mean ± standard deviation (SD), median with interquartile range, or n (%), depending on distribution. Normality was assessed prior to further analysis using the probability-probability plot. The value and burden of the PROMs were analyzed using the QQ-10 scoring method [10]. Qualitative thematic content analysis was performed on the open-ended responses to the three free-text questions at the end of the QQ-10 questionnaire [12]. Researchers (re-)read all answers provided per questionnaire to familiarize themselves with the data. Since the comments focused on either the content or design of the questionnaires, the data were first grouped into these two categories. Within each category, researchers identified potential relevant themes. Subsequently, these candidate themes were reviewed, refined, and either split or grouped, leading to the final set of themes, which highlighted areas for improvement in the questionnaires. Analyses were performed using SPSS Statistics 28.0 (IBM Corporation, Armonk, NY, USA). Ethics This study was granted exemption from the Dutch Medical Research with Human subjects Law by the Institutional Medical Ethics Review Board from the UMCG (METc 2023/428) and the study was conducted in accordance with the provisions of the Declaration of Helsinki, the International Conference on Harmonization Good Clinical Practice guideline, and applicable regulatory requirements. Results Between September 2023 and March 2024, 200 patients were included in this study, with a majority of female patients (128/200, 64%) and a mean age of 40 years (SD 13.4). Disease characteristics showed a mean IHS4 score of 5.68 (SD 8.58). The mean time to complete the questionnaires was 1.52, 1.84, and 1.51 min for the DLQI, HiSQOL and Skindex-17, respectively. All baseline characteristics are shown in Table 1. Table 1.Patient and disease characteristicsPatient characteristics N = 200​Age, mean±SD, years39.9913.35Sex1, n (%)128(64)Body mass index, mean±SD229.707.48IHS4 score, mean±SD35.688.58 Mild, n (%)107(54.0) Moderate, n (%)59(29.8) Severe, n (%)32(16.2)Refined Hurley stage3 Mild (1A, 2A), n (%)84(42.4) Moderate (1B, 2B), n (%)69(34.8) Severe (1C, 2C, 3), n (%)45(22.7)AN count, mean±SD31.842.79HiSQOL, mean±SD24.7015.40DLQI, mean±SD11.877.90Skindex-17 Psychosocial, mean±SD13.486.93 Symptoms, mean±SD5.842.40IHS4, International Hidradenitis Suppurativa Severity score system; AN, abscess and nodule; HiSQOL, Hidradenitis Suppurativa Quality of Life; DLQI, Dermatology Life Quality Index. 1Female. 2Five missing. 3Two missing. Patient and disease characteristics IHS4, International Hidradenitis Suppurativa Severity score system; AN, abscess and nodule; HiSQOL, Hidradenitis Suppurativa Quality of Life; DLQI, Dermatology Life Quality Index. 1Female. 2Five missing. 3Two missing. Value and Burden of PROMs The DLQI showed a mean value score of 15.9 (SD 3.6), corresponding to 66.3%, and mean burden score of 3.9 (SD 2.7), which equals 24.4%. For the HiSQOL, the value score was 67.1% (mean 16.1, SD 3.8), with a burden score of 23.8% (mean 3.8, SD 2.7). The Skindex-17 had a mean value score of 16.6 (SD 3.3) and a mean burden of 3.8 (SD 2.7), yielding a value of 69.2% and a burden of 23.8% (Table 2). Value and burden scores categorized by sex, age categories, and IHS4 severity showed similar results and are shown in Table 3. Table 2.Quantitative data and open-end responses in one overview​DLQIHiSQOLSkindex-17Quantitative data Value, %66.367.169.2* Burden, %24.423.823.8** Most favored, %27.031.541.5 Time to complete, mean (SD), minutes1.52 (0.63)1.84 (0.76)1.51 (0.65)Open-end responses Total comments, n845785 Content, n361954Mental health, n1066 “More attention to the mental aspect is desired” “Perhaps better to focus more on the mental aspect” “I miss aspects about mood swings” Treatment, n845HS symptoms, n6416 “I miss questions about the degree of pain” “Burning sensation” “Pain score,” “pain level” More details, n214Clothing, n204Too much intimacy, n1010​​ “Too many questions about intimate intercourse” Other, n749Design, n483831Short recall time, n201012 “Over the last 7 days I did not have any complaints, which makes it difficult to fill out the questionnaire. Without any timeframe would be better” “A time frame of 1 week is too short” “7 days does not feel representative” Textual difficulties, n1077Layout, n16146 “This questionnaire is difficult to read due to its design” “Too much text which makes it unclear” “Group questions more by theme; right now it is all over the place” Other, n1076HiSQOL, Hidradenitis Suppurativa Quality of Life; DLQI, Dermatology Life Quality Index.*1 missing.**2 missing. Quantitative data and open-end responses in one overview HiSQOL, Hidradenitis Suppurativa Quality of Life; DLQI, Dermatology Life Quality Index. *1 missing. **2 missing. Table 3.Value and burden of the PROMs, depending on sex, age, and severity​DLQIHiSQOLSkindex-17Sex Female (n = 128)*​​​​​ Value, mean (SD) (%)16.2 (3.7)67.516.3 (4.2)67.516.7 (3.5)69.6 Burden, mean (SD) (%)3.8 (2.8)23.83.7 (2.8)23.13.8 (2.7)23.8 Male (n = 72)​​​​*​ Value, mean (SD) (%)15.3 (3.2)63.815.7 (3.2)65.416.3 (2.9)67.5 Burden, mean (SD) (%)4.0 (2.7)25.04.1 (2.7)25.63.8 (2.6)23.8Age 17–40 years (n = 105)*​​​*​ Value, mean (SD) (%)16.1 (3.8)67.116.5 (3.8)68.816.9 (3.4)70.0 Burden, mean (SD) (%)3.5 (2.5)21.93.6 (2.7)22.53.4 (2.4)21.3 >40 years (n = 95)​​​​*​ Value, mean (SD) (%)15.6 (3.4)65.015.6 (3.8)65.016.2 (3.2)67.5 Burden, mean (SD) (%)4.2 (3.0)26.34.1 (2.7)25.64.1 (2.9)25.6IHS4 severity Mild(n = 107)​(n = 107)​(n = 106)​ Value, mean (SD) (%)16.3 (3.8)67.516.5 (3.5)68.816.8 (3.4)70.0 Burden, mean (SD) (%)3.5 (2.9)21.93.3 (2.7)20.13.4 (2.9)21.3 Moderate(n = 58, 59)​(n = 59)​(n = 58, 59)​ Value, mean (SD) (%)15.2 (3.3)63.315.8 (3.2)65.816.3 (2.9)67.9 Burden, mean (SD) (%)4.2 (2.5)26.34.4 (2.9)27.54.2 (2.4)26.3 Severe(n = 34)​(n = 34)​(n = 34)​ Value, mean (SD) (%)15.7 (3.5)65.415.3 (5.3)63.816.4 (3.7)68.3 Burden, mean (SD) (%)4.4 (2.6)27.54.4 (2.8)27.54.3 (2.4)26.9DLQI, Dermatology Life Quality Index; HiSQOL, Hidradenitis Suppurativa Quality of Life; IHS4, International Hidradenitis Suppurativa Severity scoring system; SD, standard deviation.*1 missing. Value and burden of the PROMs, depending on sex, age, and severity DLQI, Dermatology Life Quality Index; HiSQOL, Hidradenitis Suppurativa Quality of Life; IHS4, International Hidradenitis Suppurativa Severity scoring system; SD, standard deviation. *1 missing. Patient preference rankings revealed that the Skindex-17 was the most preferred questionnaire, with 41.5% of patients selecting it as their first choice. The HiSQOL was favored by 31.5%, while the DLQI was the least favored, with 27% of the patients choosing it as their top choice. Insights Open-End Responses Patients provided feedback through open-text fields at the end of the QQ-10 questionnaire. In total, 61, 42, and 47 patients offered feedback on the DLQI, HiSQOL, and Skindex-17, respectively. Feedback was grouped into two main categories: content and design (as outlined in Data Analysis), and areas for improvement were identified. Content Patients provided 36, 19, and 54 comments on the content of the DLQI, HiSQOL, and Skindex-17, respectively. Commonly mentioned subjects missing in all questionnaires included mental health, treatment options, and HS symptoms. “I miss questions about the smell of the wounds, wound leakage and pain scores .” And, “maybe more attention to the quality of mental well-being” or, “I think that diet and medication use can be a useful addition.” Furthermore, the DLQI and Skindex-17 lacked questions related to clothing, and the Skindex-17, in particular, was seen to overemphasize intimacy-related questions: “I miss questions about whether you need to consider what clothing you wear” and “Too much intimacy, asking once seems sufficient to me, and it’s logical that it is so.” In addition, some patients suggested that especially the Skindex-17 could benefit from additional questions to explore various issues in greater depth. “The questions could be asked in much more depth; due to the superficiality of the questions they can be greatly expanded.” Design Concerning the design of the questionnaires, 48 comments were received for the DLQI, 38 for the HiSQOL, and 31 for the Skindex-17. A total of 42 comments addressed the recall period of the PROMs, with patients indicating that the 7-day recall period was too short for evaluating HS: “Instead of focusing on just the last 7 days would it be better if we could look back to the last month or even last 4 months,” and “looking at a period of just 7 days seems not enough for me” or “I suggest questions about a longer period: last week I happened to have no issues. When the spot (1 area) flares up, everything is restricted, everything hurts, and it becomes difficult to work and it hinders me.” Additionally, several recommendations were provided regarding layout and length, particularly for the DLQI and HiSQOL, which some patients found unclear or too lengthy. Patients suggested completing the questionnaires electronically rather than on paper. “I prefer a digital version. In that case I can fill out the questionnaires at home with more peace. Especially if you just received a lot of information.” See Table 2 for an overview of all quantitative data and open-end responses. Discussion In recent years, patient perspectives have taken on a more central role in healthcare, both in research and clinical care, with increased emphasis on subjective experiences such as symptoms, disability, and quality of life. This shift has led to the development of various PROMs. The significant pain, disfigurement, disability, and stigma associated with skin diseases, which impose a substantial psychological, social, and financial burden, further highlight the importance of using PROMs in dermatology [1, 2]. Several dermatology-specific PROMs have been developed, covering various domains [13] and recently, there has also been an increased focus on creating PROMs specific to HS [8, 14–19]. Currently, the DLQI, Skindex-17, and the HS-specific HiSQOL are among the most commonly used PROMs in HS care. This observational study evaluated patients’ perceptions of these PROMs, showing comparable good value scores (DLQI: 66.3%; HiSQOL: 67.1%; Skindex-17: 69.2%) and low burden scores (both HiSQOL and Skindex-17: 23.8%, DLQI: 24.4%). These findings suggest a good face validity and feasibility of the PROMs, aligning with previous studies that reported similar burden levels for other questionnaires (17%–37%), indicating that most patients do not find these questionnaires burdensome [10]. However, value scores in our study were slightly lower than those reported in other studies (73%–77%), indicating room for improvement [20–25]. The current study showed no differences between sex, age-groups, or disease severity. Based on patient rankings, the Skindex-17 was most favored by patients, followed by the HiSQOL and DLQI. The open-end responses, however, provide a contrasting perspective. Despite its popularity, the Skindex-17 received the most negative feedback (85 comments), primarily due to a lack of HS-specific symptom coverage and an overemphasis on intimacy. The discrepancy between the Skindex-17 being the highest-ranked instrument and receiving the most negative feedback could be attributed to its clear and user-friendly layout. Similarly, the DLQI was criticized for its complex design and lack of HS-specific issues like pain, odor, and emotional well-being. Surprisingly, the HiSQOL, although HS specific, did not stand out, with most patient remarks focusing on design issues. Offering a digital version could enhance its usability. Furthermore, patients provided minimal negative feedback regarding the content of the HiSQOL. Overall, although patients generally prefer the HiSQOL for assessing the impact on quality of life, generic questionnaires remain valuable for comparing quality-of-life outcomes across different dermatological conditions. In contrast, the disease-specific HiSQOL is particularly suited for evaluating trends in HS-related issues within clinical trials or routine practice. A common concern across all questionnaires was the 7-day recall period, which patient felt was too short to reflect the fluctuating nature of HS. Many suggested extending the recall time to a month to capture periods of both flare-ups and remission, as recommended for other HS assessment tools like the cumulative IHS4 [26]. Several patients echoed this sentiment, “instead of asking about last week, ask about last month.” The authors argue that a monthly recall period would better reflect patient’s quality of life while minimizing recall bias. The results of the comparison between the PROMs, along with the generally somewhat lower mean value scores, suggest that there is still room for improvement in developing HS-specific PROMs, at least from the patient’s perspective. While numerous studies have emphasized the importance of PROMs in HS clinical practice and research, the strength of the current study is that it is, to our knowledge, the first study that evaluated patients’ view on some of the most widely used PROMs in HS care. Other strengths of this study include its large sample size, use of three different PROMs, and application of the validated QQ-10 instrument, which has been shown to have high reliability and patient acceptability [10]. The random order of PROM administration also minimized sequence bias. However, the multicenter approach prevented the use of digital questionnaires, resulting in nonuniform design across the PROMs. This inconsistency may have shifted the focus away from the content of the different PROMs, which is one of the limitations of this study. Future studies should explore preferences for various PROMs through digital questionnaires to achieve a standardized design across different PROMs. Additionally, it is possible that patients with low literacy levels chose not to participate in the study, leading to the exclusion of their insights. Finally, the study was conducted in tertiary hospitals, which could result in an overrepresentation of patients with moderate to severe disease compared to the general HS population. In conclusion, the value and burden scores of the three PROMs are comparable, indicating no clear preference from the patients’ perspective. Although patients ranked the Skindex-17 as the highest, both Skindex-17 and DLQI received the most negative open-ended responses, pointing to significant gaps in content, particularly concerning HS-specific symptoms. In contrast, the HiSQOL received minimal negative feedback, most of which focused on its design rather than its content. Given these findings, the HiSQOL might be the most suitable tool for both research and clinical practice as it provides a more comprehensive insight into the quality of life of patients by including HS-specific symptoms. Nevertheless, this study underscores the need for continued improvements in PROMs to better address the specific needs of this patient group. Statement of Ethics This study protocol was reviewed and granted exemption from the Dutch Medical Research with Human subjects Law by the Institutional Medical Ethics Review Board from the UMCG (METc 2023/428). The patients in this manuscript have given written informed consent to the publication of their case details. Conflict of Interest Statement The authors have no conflicts of interest to declare. Funding Sources This study was not supported by any sponsor or funder. Author Contributions Johanna C. van Huijstee and Nicole D.K. Koerts participated in the conception and design of the study, conducted the research, wrote the initial manuscript, and approved the final version. Colin C. Spence conducted the research, revised the manuscript, and approved the final version. Renske Schappin, Barbara Horvath, and Hessel H. van der Zee participated in the conception and design of the study, revised the manuscript, and approved the final version.